Feeling overwhelmed making sense of health data? A powerful new data set and visualization will help provide great insights into drug development and Medicare spending on drugs. Best part? The data will be freely available, courtesy of the aptly named company, Enigma.
Funded by venture capitalists and more staid investors, including the NEA and New York Times Company, Enigma is a data technology company whose main business is providing analytics to industry, using both public and proprietary data, in order to help companies make better decisions. The “Google for public data” company gleans data from billions of public records, running the gamut from climate, to patent filings, to government contracts and the government shutdown. It excels at data visualization, which is how it caught my eye.
